SPHK1 and neoplasm: Prior studies conducted by SubbaRao demonstrated that targeting SPHK1 could reduce pAkt expression and arrest cells in the G0/G1 phase of the melanoma cell cycle, thereby decreasing tumor cell proliferation and inducing apoptosis 37-38.